<- Go Home
Lattice Biologics Ltd.
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company is headquartered in Belgrade, Montana.
Market Cap
$128.00
Volume
48.8K
Cash and Equivalents
N/A
EBITDA
-$264.7K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$645.6K
Profit Margin
41.44%
52 Week High
$0.00
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
0.00
Price / Earnings
-0.00
Price / Tangible Book Value
-0.00
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$615.7K
Return on Equity
28.30%
Return on Assets
-24.95
Cash and Short Term Investments
N/A
Debt
N/A
Equity
$100.7K
Revenue
$1.6M
Unlevered FCF
N/A
Sector
Biotechnology
Category
N/A